[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]

Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
Размер217.57 Kb.
1   2   3   4   5   6   7   8
Electrophoresis 26 (4-5): 885-894, 2005

Li XX; Zhao MW; Yu WZ. [Recent advances of clinical and basic studies of ocular fundus diseases in China in the last five years]. Zhonghua Yan Ke Za Zhi 41 (8): 717-723, 2005

Lilge L; Vesselov L; Whittington W. Thin cylindrical diffusers in multimode Ge-doped silica fibers. Lasers Surg Med 36 (3): 245-251, 2005

Lim DS; Ko SH; Lee CH; Ahn WS; Lee WY. DH-I-180-3 Mediated Photodynamic Therapy: Its Biodistribution and Tumor Vascular Damage. Photochem Photobiol , 2005

Lis-Swiety A; Brzezinska-Wcislo L; Wcislo-Dziadecka D; Kaminska-Winciorek G. [Photodynamic therapy in dermatology]. Pol Merkuriusz Lek 18 (105): 354-357, 2005

Liu Q; Hamblin MR. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state. Int J Immunopathol Pharmacol 18 (3): 391-402, 2005

Liu W; Jensen TJ; Fronczek FR; Hammer RP; Smith KM; Vicente MG. Synthesis and cellular studies of nonaggregated water-soluble phthalocyanines. J Med Chem 48 (4): 1033-1041, 2005

Lobanov AV; Uzdensky AB. PDT-induced death of sensory neurons and glial cells in the isolated crayfish stretch receptor after proteolytic treatment. J Neurosci Res , 2005

Loganathan D; Morrison H. 'Photocisplatin' reagents. Curr Opin Drug Discov Devel 8 (4): 478-486, 2005

Loidl W; Schmidbauer J; Susani M; Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 47 (3): 323-326, 2005

Lovat LB; Jamieson NF; Novelli MR; Mosse CA; Selvasekar C; Mackenzie GD; Thorpe SM; Bown SG. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc 62 (4): 617-623, 2005

Low U; Kohlhof JK; Ruprecht KW. [Does acetylsalicylic acid have a negative influence on photodynamic therapy?]. Ophthalmologe , 2005

Ma J; Ke Y; Wu D; Gu X; Gao R. Experimental study on relationship between retinal vein occlusion and loss of vitreous gel mass. Mol Vis 11: 744-748, 2005

Maberley DA; Chew H; Ma P; Chang A; Hollands H; Maberley A. Comparison of photodynamic therapy and transpupillary thermotherapy for subfoveal choroidal neovascularization due to age-related macular degeneration. Can J Ophthalmol 40 (3): 378-383, 2005

Magaraggia M; Visona A; Furlan A; Pagnan A; Miotto G; Tognon G; Jori G. Inactivation of vascular smooth muscle cells photosensitised by liposome-delivered Zn(II)-phthalocyanine. J Photochem Photobiol B , 2005

Maharaj DS; Molell H; Antunes EM; Maharaj H; Maree DM; Nyokong T; Glass BD; Daya S. Melatonin generates singlet oxygen on laser irradiation but acts as a quencher when irradiated by lamp photolysis. J Pineal Res 38 (3): 153-156, 2005

Maisch T; Szeimies RM; Lehn N; Abels C. [Antibacterial photodynamic therapy A new treatment for bacterial skin diseases?]. Hautarzt 56 (11): 1048-1055, 2005

Maisch T; Bosl C; Szeimies RM; Lehn N; Abels C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother 49 (4): 1542-1552, 2005

Marchal S; Fadloun A; Maugain E; D'Hallewin MA; Guillemin F; Bezdetnaya L. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem Pharmacol 69 (8): 1167-1176, 2005

Marmur ES; Phelps R; Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 7 (1): 21-24, 2005

Maruyama T. [Intraoperative photodynamic diagnosis using 5-ALA for glioma surgery]. Nippon Rinsho 63 Suppl 9: 380-388, 2005

Mauget-Faysse M; Dubois E; Quaranta M; Osternaud S; Vettard S. [Low-vision rehabilitation of age-related macular degeneration patients with retrofoveal choroidal new-vessels treated with photodynamic therapy with verteporfin]. J Fr Ophtalmol 28 (4): 372-379, 2005

Maunoury V; Mordon S; Bulois P; Mirabel X; Hecquet B; Mariette C. Photodynamic therapy for early oesophageal cancer. Dig Liver Dis 37 (7): 491-495, 2005

Mazor O; Brandis A; Plaks V; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A. WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochem Photobiol 81 (2): 342-351, 2005

Mazzucchelli R; Barbisan F; Tarquini LM; Streccioni M; Galosi AB. Urothelial changes induced by therapeutic procedures for bladder cancer. A review. Anal Quant Cytol Histol 27 (1): 27-34, 2005

McCarron PA; Donnelly RF; Woolfson AD; Andrews GP. Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation. J Pharm Biomed Anal 36 (5): 1099-1105, 2005

McCarron PA; Donnelly RF; Zawislak A; Woolfson AD; Price JH; McClelland R. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm 293 (1-2): 11-23, 2005

McCarron PA; Donnelly RF; Andrews GP; Woolfson AD. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J Pharm Sci 94 (8): 1756-1771, 2005

McDonnell SO; Hall MJ; Allen LT; Byrne A; Gallagher WM; O'shea DF. Supramolecular Photonic Therapeutic Agents. J Am Chem Soc 127 (47): 16360-16361, 2005

Meerovich IG; Smirnova ZS; Oborotova NA; Luk'yanets EA; Meerovich GA; Derkacheva VM; Polozkova AP; Kubasova IY; Baryshnikov AY. Hydroxyaluminium tetra-3-phenylthiophthalocyanine is a new effective photosensitizer for photodynamic therapy and fluorescent diagnosis. Bull Exp Biol Med 139 (4): 427-430, 2005

Meerovich IG; Jerdeva V; Derkacheva VM; Meerovich GA; Lukyanets EA; Kogan EA; Savitsky AP. Photodynamic activity of dibiotinylated aluminum sulfophthalocyanine in vitro and in vivo. J Photochem Photobiol B 80 (1): 57-64, 2005

Mehta HB; Shanmugam MP. Photodynamic therapy of a posttraumatic choroidal neovascular membrane. Indian J Ophthalmol 53 (2): 131-132, 2005

Meisel P; Kocher T. Photodynamic therapy for periodontal diseases: state of the art. J Photochem Photobiol B 79 (2): 159-170, 2005

Melendez RF; Kumar N; Maswadi SM; Zaslow K; Glickmank RD. Photodynamic actions of indocyanine green and trypan blue on human lens epithelial cells in vitro. Am J Ophthalmol 140 (1): 132-134, 2005

Melnick S. Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation. J Drugs Dermatol 4 (6): 742-745, 2005

Mennel S; Callizo J; Meyer CH; Kroll P. [Subjective decrease of visual acuity after photodynamic therapy: documentation by optical coherence tomography and its correlation with visual acuity]. Arch Soc Esp Oftalmol 80 (7): 413-416, 2005

Mennel S; Hausmann N; Meyer CH; Horle S; Peter S. [Transient visual decrease after photodynamic therapy]. Ophthalmologe 102 (1): 58-63, 2005

Mennel S; Liu F; Meyer CH. Optical coherence tomography in photodynamic therapy. Br J Ophthalmol 89 (7): 928-929, 2005

Mennel S; Hausmann N; Meyer CH; Peter S. Photodynamic therapy and indocyanine green guided feeder vessel photocoagulation of choroidal neovascularization secondary to choroid rupture after blunt trauma. Graefes Arch Clin Exp Ophthalmol 243 (1): 68-71, 2005

Mennel S; Meyer CH; Eggarter F; Peter S. Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy. Am J Ophthalmol 140 (4): 758-760, 2005

Mennel S; Meyer CH. Transient visual disturbance after photodynamic therapy. Am J Ophthalmol 139 (4): 748-749, 2005

Meyer CH; Lapolice DJ; Fekrat S. Functional changes after photodynamic therapy with verteporfin. Am J Ophthalmol 139 (1): 214-215, 2005

Meyer S; Landthaler M; Hohenleutner S. [Long-term course of necrobiotic xanthogranuloma with ocular involvement.]. Hautarzt , 2005

Mi QW; Cao ZG; Jia T; Zhou SW; Liu JH; Song XD; Li ZY; Ye ZQ. [Effect of photodynamic therapy with metalloporphyrin compound on human prostate cancer PC-3 cells in vitro]. Zhonghua Nan Ke Xue 11 (2): 124-6, 129, 2005

Michels S; Michels R; Simader C; Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina 25 (6): 697-703, 2005

Mikasa K; Watanabe D; Kondo C; Kobayashi M; Nakaseko H; Yokoo K; Tamada Y; Matsumoto Y. 5-Aminolevulinic acid-based photodynamic therapy for the treatment of two patients with extramammary Paget's disease. J Dermatol 32 (2): 97-101, 2005

Mikasa K; Watanabe D; Kondo C; Tamada Y; Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol 53 (5): 911-912, 2005

Milanesio ME; Alvarez MG; Rivarola V; Silber JJ; Durantini EN. Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitizers for photodynamic therapy. Photochem Photobiol 81 (4): 891-897, 2005

Mirshahi A; Schreyger F; Baatz H; Scharioth GB. [Macular translocation after photodynamic therapy: a case report]. Klin Monatsbl Augenheilkd 222 (7): 586-589, 2005

Misawa J; Moriwaki S; Kohno E; Hirano T; Tokura Y; Takigawa M. The role of low-density lipoprotein receptors in sensitivity to killing by Photofrin-mediated photodynamic therapy in cultured human tumor cell lines. J Dermatol Sci 40 (1): 59-61, 2005

Misra RB; Lal K; Farooq M; Hans RK. Effect of solar UV radiation on earthworm (Metaphire posthuma). Ecotoxicol Environ Saf 62 (3): 391-396, 2005

Mitra AP; Datar RH; Cote RJ. Molecular staging of bladder cancer. BJU Int 96 (1): 7-12, 2005

Mitra S; Foster TH. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem Photobiol 81 (4): 849-859, 2005

Mitra S; Maugain E; Bolotine L; Guillemin F; Foster TH. Temporally and Spatially Heterogeneous Distribution of mTHPC in a Murine Tumor Observed by Two-color Confocal Fluorescence Imaging and Spectroscopy in a Whole-mount Model. Photochem Photobiol 81 (5): 1123-1130, 2005

Miyazawa S; Nishida K; Komiyama T; Nakae Y; Takeda K; Yorimitsu M; Kitamura A; Kunisada T; Ohtsuka A; Inoue H. Novel transdermal photodynamic therapy using ATX-S10.Na(II) induces apoptosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Rheumatol Int : 1-9, 2005

Miyazu YM; Miyazawa T; Hiyama K; Kurimoto N; Iwamoto Y; Matsuura H; Kanoh K; Kohno N; Nishiyama M; Hiyama E. Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 65 (21): 9623-9627, 2005

Moore CM; Hoh IM; Bown SG; Emberton M. Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer? BJU Int 96 (6): 754-758, 2005

Mordon S; Maunoury V; Bulois P; Ducrotte P; Rochon P; Boyer J. [Photodynamic therapy in gastroenterology]. Gastroenterol Clin Biol 29 (8-9): 949-954, 2005

Morton CA; Scholefield RD; Whitehurst C; Birch J. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. J Dermatolog Treat 16 (4): 219-223, 2005

Morton CA. Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option? Australas J Dermatol 46 Suppl: S21-S22, 2005

Morton CA. Topical photodynamic therapy for Bowen's disease. Australas J Dermatol 46 Suppl: S11-S15, 2005

Moseley H. Light distribution and calibration of commercial PDT LED arrays. Photochem Photobiol Sci 4 (11): 911-914, 2005

Moshfeghi AA; Puliafito CA. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs 14 (5): 671-682, 2005

Muller D; Wiedmann M; Kluge R; Berr F; Mossner J; Sabri O; Caca K. [Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]. Z Gastroenterol 43 (5): 439-443, 2005

Naeser K. [Photodynamic therapy of senile macular degeneration]. Ugeskr Laeger 167 (14): 1540-1541, 2005

Nagaoka Y; Otsu K; Okada F; Sato K; Ohba Y; Kotani N; Fujii J. Specific inactivation of cysteine protease-type cathepsin by singlet oxygen generated from naphthalene endoperoxides. Biochem Biophys Res Commun 331 (1): 215-223, 2005

Nazarova AI; Feofanov AV; Karmakova TA; Sharonov GV; Pliutinskaia AD; Iakubovskaia RI; Lebedeva VS; Mironov AF; Maurizot JC; Vigny P. [Effect of substituents on photochemical and biological properties of 13,15-N-cycloimide derivatives of chlorin p6]. Bioorg Khim 31 (5): 535-548, 2005

Nestor MS. Prophylaxis for and treatment of uncomplicated skin and skin structure infections in laser and cosmetic surgery. J Drugs Dermatol 4 (6 Suppl): s20-s25, 2005

Neugebauer J. Using photodynamic therapy to treat peri-implantitis. Interview. Dent Implantol Update 16 (2): 9-16, 2005

Niedre MJ; Yu CS; Patterson MS; Wilson BC. Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid. Br J Cancer 92 (2): 298-304, 2005

Nielsen KP; Juzeniene A; Juzenas P; Stamnes K; Stamnes JJ; Moan J. Choice of Optimal Wavelength for PDT: The Significance of Oxygen Depletion. Photochem Photobiol 81 (5): 1190-1194, 2005

Nioka S; Chance B. NIR spectroscopic detection of breast cancer. Technol Cancer Res Treat 4 (5): 497-512, 2005

Niziolek M; Korytowski W; Girotti AW. Self-Sensitized Photodegradation Of Membrane-Bound Protoporphyrin Mediated By Chain Lipid Peroxidation: Inhibition By Nitric Oxide With Sustained Singlet Oxygen Damage. Photochem Photobiol , 2005

Noh KW; Woodward TA; Wallace MB. Emerging endoscopic techniques in oncology. Gastrointest Endosc Clin N Am 15 (3): 615-6xi, 2005

Norman RA. Past and future: porphyria and porphyrins. Skinmed 4 (5): 287-292, 2005

Nowakowski Z; Stelmachow J; Spiewankiewicz B; Gerulewicz G; Chem MK. Diagnostic value of the photodynamic method in the evaluation of lesions of the uterine cervix. Eur J Gynaecol Oncol 26 (3): 315-322, 2005

Nowakowski Z; Stelmachow J; Spiewankiewicz B; Gerulewicz G. Diagnostic value of the PDD method in evaluation of vulvar lesions. Eur J Gynaecol Oncol 26 (1): 75-78, 2005

Nowis D; Makowski M; Stoklosa T; Legat M; Issat T; Golab J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 52 (2): 339-352, 2005

Nybaek H; Jemec GB. Photodynamic therapy in the treatment of rosacea. Dermatology 211 (2): 135-138, 2005

Oberdanner CB; Plaetzer K; Kiesslich T; Krammer B. Photodynamic treatment with fractionated light decreases production of reactive oxygen species and cytotoxicity in vitro via regeneration of glutathione. Photochem Photobiol 81 (3): 609-613, 2005

Ohara S; Koike T; Sekine H; Iijima K; Shimosegawa T. [Endoscopic therapy for Barrett's esophagus].
1   2   3   4   5   6   7   8


[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:

База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Главная страница